SEC Info - Dupont E I De Nemours & Co - ‘10-Q’ for 3/31/17

SEC Info℠

Home

Help

Please Sign In

Dupont E I De Nemours & Co – ‘10-Q’ for 3/31/17 – ‘EX-101.SCH’

On: Tuesday, 4/25/17, at 3:28pm ET · For: 3/31/17 · Accession #: 30554-17-16 · File #: 1-00815

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/25/17  Dupont E I De Nemours & Co        10-Q        3/31/17   81:9.5M

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    527K 
 2: EX-10.16    Material Contract                                   HTML    114K 
 3: EX-10.23    Material Contract                                   HTML    140K 
 4: EX-10.25    Material Contract                                   HTML   1.17M 
 5: EX-12       Statement re: Computation of Ratios                 HTML     32K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
16: R1          Document and Entity Information                     HTML     43K 
17: R2          Consolidated Income Statements                      HTML     91K 
18: R3          Consolidated Statements of Comprehensive Income     HTML     52K 
19: R4          Condensed Consolidated Balance Sheets               HTML    121K 
20: R5          Condensed Consolidated Balance Sheets               HTML     36K 
                (Parenthetical)                                                  
21: R6          Condensed Consolidated Statements of Cash Flows     HTML    103K 
22: R7          Summary of Significant Accounting Policies          HTML     47K 
23: R8          Planned Merger with Dow Chemical Planned Merger     HTML     38K 
                with Dow Chemical                                                
24: R9          Divestitures and Other Transactions                 HTML     38K 
25: R10         Employee Separation / Asset Related Charges, Net    HTML     65K 
26: R11         Other Income, Net                                   HTML     62K 
27: R12         Provision for Income Taxes                          HTML     30K 
28: R13         Earnings Per Share of Common Stock                  HTML     51K 
29: R14         Inventories                                         HTML     35K 
30: R15         Other Intangible Assets                             HTML     79K 
31: R16         Short-Term and Long-Term Borrowings                 HTML     31K 
32: R17         Commitments and Contingent Liabilities              HTML     83K 
33: R18         Stockholders' Equity                                HTML    133K 
34: R19         Financial Instruments                               HTML    142K 
35: R20         Long-Term Employee Benefits                         HTML     58K 
36: R21         Segment Information                                 HTML    101K 
37: R22         Summary of Significant Accounting Policies Summary  HTML     47K 
                of Significant Accounting Policies (Policies)                    
38: R23         Employee Separation / Asset Related Charges, Net    HTML     61K 
                (Tables)                                                         
39: R24         Other Income, Net (Tables)                          HTML     62K 
40: R25         Earnings Per Share of Common Stock (Tables)         HTML     52K 
41: R26         Inventories (Tables)                                HTML     36K 
42: R27         Other Intangible Assets (Tables)                    HTML     76K 
43: R28         Commitments and Contingent Liabilities (Tables)     HTML     52K 
44: R29         Stockholders' Equity (Tables)                       HTML    130K 
45: R30         Financial Instruments (Tables)                      HTML    129K 
46: R31         Long-Term Employee Benefits (Tables)                HTML     57K 
47: R32         Segment Information (Tables)                        HTML    102K 
48: R33         Summary of Significant Accounting Policies Summary  HTML     33K 
                of Significant Accounting Policies (Narrative)                   
                (Details)                                                        
49: R34         Planned Merger with Dow Chemical Planned Merger     HTML     36K 
                with Dow Chemical (Narrative) (Details)                          
50: R35         Divestitures and Other Transactions (Narrative)     HTML     56K 
                (Details)                                                        
51: R36         Employee Separation / Asset Related Charges, Net    HTML     61K 
                Employee Separation / Asset Related Charges, Net                 
                (2017 Restructuring Program schedule) (Details)                  
52: R37         Employee Separation / Asset Related Charges, Net    HTML     36K 
                Employee Separation / Asset Related Charges, Net                 
                (La Porte) (Narrative) (Details)                                 
53: R38         Employee Separation / Asset Related Charges, Net    HTML     66K 
                Employee Separation / Asset Related Charges, Net                 
                (2016 Restructuring Program schedule )(Details)                  
54: R39         Other Income, Net (Schedule of Other Income)        HTML     66K 
                (Details)                                                        
55: R40         Other Income, Net (Schedule of Foreign Exchange     HTML     36K 
                Gain (Loss)) (Details)                                           
56: R41         Provision for Income Taxes (Details)                HTML     32K 
57: R42         Earnings Per Share of Common Stock (Earnings Per    HTML     48K 
                Share of Common Stock Reconciliation) (Details)                  
58: R43         Earnings Per Share of Common Stock (Schedule of     HTML     29K 
                Average Number of Antidilutive Stock Options)                    
                (Details)                                                        
59: R44         Inventories (Details)                               HTML     37K 
60: R45         Other Intangible Assets (Schedule of Other          HTML     66K 
                Intangible Assets) (Details)                                     
61: R46         Other Intangible Assets (Narrative) (Details)       HTML     44K 
62: R47         Short-Term and Long-Term Borrowings (Details)       HTML     57K 
63: R48         Commitments and Contingent Liabilities              HTML     55K 
                (Guarantees) (Details)                                           
64: R49         Commitments and Contingent Liabilities              HTML    122K 
                (Litigation) (Narrative) (Details)                               
65: R50         Commitments and Contingent Liabilities Commitments  HTML     38K 
                and Contingent Liabilities (Environmental)                       
                (Narrative) (Details)                                            
66: R51         Stockholders' Equity Stockholder's Equity           HTML     59K 
                (Details)                                                        
67: R52         Stockholders' Equity Stockholder's Equity           HTML     30K 
                (Schedule of tax benefit (Expense) on Net                        
                Activity) (Details) (Details)                                    
68: R53         Stockholders' Equity Stockholders' Equity           HTML     68K 
                (Reclassifications out of accumulated other                      
                Comprehensive Income / (Loss)) (Details) (Details)               
69: R54         Financial Instruments Financial Insttruments        HTML     51K 
                (Schedule of Cash, Cash Equivalents and Marketable               
                Securities) (Details)                                            
70: R55         Financial Instruments (Debt) (Narrative) (Details)  HTML     26K 
71: R56         Financial Instruments (Notional Amounts of          HTML     32K 
                Derivatives) (Details)                                           
72: R57         Financial Instruments (Effect of Cash Flows Hedges  HTML     38K 
                on Accumulated Other Comprehensive Income (Loss))                
                (Details)                                                        
73: R58         Financial Instruments (Schedule of the Fair Value   HTML     52K 
                of Derivative Instruments) (Details)                             
74: R59         Financial Instruments (Effect of Derivative         HTML     52K 
                Instruments) (Details)                                           
75: R60         Long-Term Employee Benefits (Schedules of Net       HTML     59K 
                Periodic Benefit Cost) (Details)                                 
76: R61         Segment Information (Schedule of Segment            HTML     48K 
                Information) (Details)                                           
77: R62         Segment Information (Reconciliation to              HTML     68K 
                Consolidated Income Statements) (Details)                        
78: R63         Segment Information (Significant Pre-tax (charges)  HTML     86K 
                benefits not included in Segment Operating                       
                Earnings) (Details)                                              
80: XML         IDEA XML File -- Filing Summary                      XML    143K 
79: EXCEL       IDEA Workbook of Financial Reports                  XLSX     89K 
10: EX-101.INS  XBRL Instance -- dd-20170331                         XML   2.43M 
12: EX-101.CAL  XBRL Calculations -- dd-20170331_cal                 XML    198K 
13: EX-101.DEF  XBRL Definitions -- dd-20170331_def                  XML    940K 
14: EX-101.LAB  XBRL Labels -- dd-20170331_lab                       XML   1.57M 
15: EX-101.PRE  XBRL Presentations -- dd-20170331_pre                XML   1.03M 
11: EX-101.SCH  XBRL Schema -- dd-20170331                           XSD    201K 
81: ZIP         XBRL Zipped Folder -- 0000030554-17-000016-xbrl      Zip    251K

‘EX-101.SCH’ — XBRL Schema — dd-20170331

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dupont.com/20170331" xmlns:dd="http://www.dupont.com/20170331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">

<xsd:import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-roles/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-roles-2016-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>

<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/country/2016-01-31" schemaLocation="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/currency/2016-01-31" schemaLocation="http://xbrl.sec.gov/currency/2016/currency-2016-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/exch/2016-01-31" schemaLocation="http://xbrl.sec.gov/exch/2016/exch-2016-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>

<xsd:annotation>

<xsd:appinfo>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dd-20170331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dd-20170331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dd-20170331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dd-20170331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>

<link:roleType id="CommitmentsAndContingentLiabilities" roleURI="http://www.dupont.com/role/CommitmentsAndContingentLiabilities">

<link:definition> 2118100 - Disclosure - Commitments and Contingent Liabilities </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>